Dow Down 1.40% Nasdaq Down 1.59%

Array BioPharma, Inc. (ARRY)

-NasdaqGM
3.48 Down 0.09(2.52%) Oct 1, 4:00PM EDT
Prev Close:3.57
Open:3.61
Bid:3.24 x 500
Ask:3.68 x 500
1y Target Est:7.14
Beta:2.41
Next Earnings Date: 4-Nov-14ARRY Earnings announcement
Day's Range:3.33 - 3.62
52wk Range:3.33 - 6.66
Volume:2,186,152
Avg Vol (3m):1,413,100
Market Cap:458.74M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARRY

Comparison

Symbol% ChgMkt Cap
ARRYDown 2.52%458.74M
ARQLDown 2.68%68.42M
BMYDown 0.57%83.77B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.18
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.79
Quarterly EPS Est (Sep-14) :-0.22
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-0.48

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer in North America, Europe, and the Asia Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback